Chinese Biotech Firm Realbio Raises Nearly $15M Series A+ Round

Chinese biotechnology firm Realbio Technology has raised nearly RMB100 million (US$14.93 million) in a series A round of financing led by Chinese venture capital firm Shandong Luxin High-Tech Industry, according to a statement released on Wednesday.

(more…)

Chinese Biotech Firm Realbio Raises Nearly $15M Series A+ Round comes originally from Continue Reading the Entire Article Here >>

This news article comes via China Money Network, who is the copyright owner of this information and news. FintekAsia.com has licensed the rights to this article and any republication or re-distribution in whole or in part of this content is strictly prohibited without the express consent of

You May Also Like

China’s Services Sector Accounts For 56% Of GDP, But Does It Matter?

H&Q Asia Pacific Leads $15M Series C Round In Efficient Drivetrains

Alibaba-Backed Chinese AI Unicorn Megvii Eyes Hong Kong IPO